Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial - Grothey, A; Van Cutsem, E; Sobrero, A (Lancet, 2013)
(9863):